Cadila Pharmaceuticals Market Research Report

Company Overview

Name:

Cadila Pharmaceuticals

Mission of the Company

Cadila Pharmaceuticals aims to be a leading pharmaceutical company in India and a significant global player by offering high-quality, affordable, and innovative solutions in medicine and treatment.

Founded and By Whom

Founded: 1951

Founder: Shri Indravadan A. Modi

Key People in the Company

Chairman and Managing Director: Dr. Rajiv I. Modi

Headquarters

Location: Gujarat, India

Number of Employees

Over 8,000 employees

Revenue

No information is available

What is the Company Known For?

Cadila Pharmaceuticals is known for its pioneering role in the Indian pharmaceutical sector, manufacturing "first-in-the-world" innovations in lung cancer, tuberculosis, cardiovascular, and gastroenterology fields.

Products

Offerings

1. APIs

Description: Cadila is a top manufacturer of Active Pharmaceuticals Ingredients (APIs) across various therapeutic categories like respiratory, diabetology, gastroenterology, and more.

Key Features: Vertically integrated production facility, accredited by global organizations.

2. Formulations

Description: An extensive range encompassing over 850 products across 45 therapeutic segments.

Key Features: Produced in state-of-the-art facilities, includes cardiovascular, gastrointestinal, analgesics, oncology, and more.

3. Contract Research Operation (CRO)

Description: Pre-clinical and clinical trial services covering 45 therapeutic categories.

Key Features: Accredited facilities, over 1000 pre-clinical studies and 28 clinical trials conducted.

High-Level Description of the Product

Cadila Pharmaceuticals synthesizes quality API solutions and offers comprehensive finished dosage formulations spanning countless therapeutic areas. Their robust research division focuses on addressing unmet medical needs, establishing the company as a global hub for pharmaceutical innovation.

Recent Developments

Recent Developments in the Company

Cadila Pharmaceuticals continues to maintain a strong presence globally, with its Chairman Dr. Rajiv Modi being recognized among the "Most Promising Business Leaders of Asia."

New Products Launched

No information is available

New Features Added to the Existing Products

No information is available

Any New Partnerships

No information is available

Company Legacy

Cadila Pharmaceuticals was founded with a vision to provide affordable medicines to Indian masses, significantly changing the nation's healthcare landscape. Under the leadership of Dr. Rajiv I. Modi, the company has expanded globally, emphasizing innovation and adherence to international quality standards.

Manufacturing Facilities and Accreditations

Manufacturing Plants: 5 globally accredited plants

Accreditations: USFDA, EU, TGA Australia, WHO Geneva, and more, ensuring adherence to the highest international quality standards.

Research & Development

Cadila's R&D department, with 350 scientists, is dedicated to discovering novel treatments and ensuring robust API and formulation development to meet evolving global healthcare demands.

Corporate Governance

Cadila Pharmaceuticals adheres to stringent corporate governance guidelines, ensuring transparency and accountability in all business operations.

Conclusion

Cadila Pharmaceuticals remains a cornerstone of innovation in the pharmaceutical industry, driven by a mission to make healthcare accessible and affordable globally. The company's extensive product portfolio, rigorous R&D efforts, and strategic leadership continue to position it as a pioneering force in the industry.

Note: This report provides details based solely on the available data. Any sections marked "No information is available" were not included due to a lack of data.